NLC - The European Healthtech Venture Builder

NLC Health Ventures is a European healthtech venture builder and early-stage investor focused on bridging the gap between scientific discoveries and market-ready solutions. Their mission is to transform patient lives by finding, building, and scaling the next generation of health innovations. They employ an entrepreneurial approach at scale, aiming to build 25 ventures per year, leveraging shared learnings and resources across their portfolio of over 100 ventures. This scaled approach increases the likelihood of bringing ideas to market and reduces risk for investors. NLC operates captive funds to scale ventures faster. NLC aims to make early-stage healthcare innovation investments accessible to both retail and institutional investors. They assess over 1500 technologies annually and have built over 110 ventures. Their expertise spans several key areas within healthcare, including cardiovascular & IGT, orthopedics & spine, therapeutics, and new markets (general healthtech). NLC emphasizes a culture of innovation and positive impact on healthcare and society. They prioritize connecting different perspectives and encouraging the exchange of ideas. They value decisiveness and optimism to effectively transform healthtech innovations. The company encourages its team to explore, question, and innovate, turning challenges into opportunities to advance global health. Their core values – Together, Open, Decisive, and Optimistic (TODO) – encapsulate their culture.

Cardiovascular & IGT, Orthopedics & Spine, Therapeutics (Biotech), General Healthtech (New Markets)

Thematische Schwerpunkte und Zielmarktsegmente von Interesse.